Leber’s hereditary optic neuropathy

DBCOND0089491Congenital, Hereditary, and Neonatal Diseases and AbnormalitiesEye Disease

Leber’s hereditary optic neuropathy is the indication for 1 drug in DrugBank. It is covered by 1 curated, structured indication.

Also known as
Leber's Hereditary Optic Neuropathy · Leber Hereditary Optic Neuropathy · Leber's Hereditary Optic Neuropathy (LHON) · Leber Hereditary Optic Neuropathy (LHON) · Leber's hereditary optic atrophy neuropathy
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHM0333667ICD-10H47.22SNOMED CT230510002MedDRA10019895UMLSC0029125

What you can answer from here — as of November 06, 2026

1Indicated drugWith each drug's targets and mechanism
Listed above
1Structured indicationPopulation, line of therapy, route and combination as fields, not prose
Sign in
20Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which approved drugs for Leber’s hereditary optic neuropathy share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In